Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (71-80 of 341) with videos related to

Pageof 35
Sort By:
Reviews in Cardiovascular Medicine|July 29, 2008
Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertensionGeorge L Bakris, Michael A Weber
Hypertension (Dallas, Tex. : 1979)|April 17, 2008
Angiotensin-converting enzyme inhibitors and angioedema: estimating the riskMichael A Weber, Franz H Messerli
Hypertension (Dallas, Tex. : 1979)|March 20, 2024
Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to TodayGeorge L Bakris, Michael A Weber
The American Journal of Cardiology|April 27, 2025
Renal Denervation for Hypertension: From Innovation to IndicationRaymond R Townsend, Michael A Weber
JACC. Cardiovascular Interventions|February 5, 2021
Improved Understanding of Renal Nerve Anatomy: An Opportunity to Enhance Denervation Treatment of HypertensionMichael A Weber, John W Osborn
The American Journal of Geriatric Cardiology|January 5, 2008
Progress in treating hypertensionMichael A Weber, Nanette K Wenger
The Canadian Journal of Cardiology|March 22, 2015
Global burden of cardiovascular disease and stroke: hypertension at the coreDaniel T Lackland, Michael A Weber
The American Journal of Geriatric Cardiology|September 10, 2003
New frontiers in cardiovascular agingMichael A Weber, Nanette K Wenger, Stephen Scheidt
The American Journal of Geriatric Cardiology|March 8, 2003
A spectrum of clinical issues in geriatric cardiologyMichael A Weber, Stephen Scheidt, Nanette K Wenger
The American Journal of Geriatric Cardiology|November 7, 2006
Who should be treated with implantable cardioverter-defibrillators?Michael A Weber, Nanette K Wenger, Stephen Scheidt
Pageof 35

Showing results (71-80 of 341) with videos related to

Sort By:
Pageof 35
Reviews in Cardiovascular Medicine|July 29, 2008
Appropriate dose transition to a controlled-release formulation of carvedilol in patients with hypertensionGeorge L Bakris, Michael A Weber
Hypertension (Dallas, Tex. : 1979)|April 17, 2008
Angiotensin-converting enzyme inhibitors and angioedema: estimating the riskMichael A Weber, Franz H Messerli
Hypertension (Dallas, Tex. : 1979)|March 20, 2024
Overview of the Evolution of Hypertension: From Ancient Chinese Emperors to TodayGeorge L Bakris, Michael A Weber
The American Journal of Cardiology|April 27, 2025
Renal Denervation for Hypertension: From Innovation to IndicationRaymond R Townsend, Michael A Weber
JACC. Cardiovascular Interventions|February 5, 2021
Improved Understanding of Renal Nerve Anatomy: An Opportunity to Enhance Denervation Treatment of HypertensionMichael A Weber, John W Osborn
The American Journal of Geriatric Cardiology|January 5, 2008
Progress in treating hypertensionMichael A Weber, Nanette K Wenger
The Canadian Journal of Cardiology|March 22, 2015
Global burden of cardiovascular disease and stroke: hypertension at the coreDaniel T Lackland, Michael A Weber
The American Journal of Geriatric Cardiology|September 10, 2003
New frontiers in cardiovascular agingMichael A Weber, Nanette K Wenger, Stephen Scheidt
The American Journal of Geriatric Cardiology|March 8, 2003
A spectrum of clinical issues in geriatric cardiologyMichael A Weber, Stephen Scheidt, Nanette K Wenger
The American Journal of Geriatric Cardiology|November 7, 2006
Who should be treated with implantable cardioverter-defibrillators?Michael A Weber, Nanette K Wenger, Stephen Scheidt
Pageof 35